Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.

Novartis Investigative Site, Berlin

Novartis Investigative Site, Berlin

Novartis Investigative Site, Berlin

Novartis Investigative Site, Geesthacht

Novartis Investigative Site, Potsdam

Novartis Investigative Site, Potsdam

Novartis Investigative Site, Rüdersdorf

Novartis Investigative Site, Teterow

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Großhansdorf

Novartis Investigative Site, Lübeck

Novartis Investigative Site, Lübeck

Novartis Investigative Site, Kassel

Novartis Investigative Site, Marburg

Novartis Investigative Site, Münster

Novartis Investigative Site, Rheine

Novartis Investigative Site, Cologne

Novartis Investigative Site, Düren

Novartis Investigative Site, Euskirchen

Novartis Investigative Site, Koblenz

Novartis Investigative Site, Aschaffenburg

Novartis Investigative Site, Saarbrücken

Novartis Investigative Site, Neunkirchen

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Wiesloch

Novartis Investigative Site, Erlangen

Novartis Investigative Site, Höchstadt an der Aisch

Novartis Investigative Site, Cottbus

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Leipzig